Bitter melon reduces head and neck squamous cell carcinoma growth by targeting c-Met signaling

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Head and neck squamous cell carcinoma (HNSCC) presents significant treatment challenges with limited survival improvements.
• There is a critical need for novel therapeutic strategies to combat HNSCC.

Purpose of the Study:

• To investigate the therapeutic potential of bitter melon extract (BME) in head and neck squamous cell carcinoma (HNSCC).
• To determine if BME modulates key signaling pathways and inhibits HNSCC tumor growth in preclinical models.

Main Methods:

• In vitro studies using HNSCC cell lines treated with BME.
• Mechanistic investigations into signaling pathways affected by BME, including c-Met, phosphoStat3, c-myc, and Mcl-1.
• In vivo studies involving mice bearing HNSCC xenograft tumors fed with BME.

Main Results:

• BME treatment reduced cell proliferation in HNSCC cell lines.
• BME inhibited the c-Met signaling pathway and its downstream molecules (phosphoStat3, c-myc, Mcl-1) in HNSCC cells.
• BME administration in mice significantly inhibited HNSCC xenograft tumor growth and reduced c-Met expression.

Conclusions:

• Bitter melon extract (BME) demonstrates potential as a therapeutic agent for HNSCC.
• BME exerts its anti-cancer effects by modulating multiple signaling pathways, including the c-Met pathway.
• Further research into BME as a treatment for HNSCC is warranted.